thermozymocidin and Coronary-Disease

Heart disease is widely believed to develop from two pathological processes. Circulating lipoproteins containing the nondegradable lipid, cholesterol, accumulate within the arterial wall and perhaps are oxidized to more toxic lipids. Both lipid accumulation and vascular reaction to the lipids lead to the gradual thickening of the vascular wall. A second major process that in some circumstances is a primary event is the development of a local inflammatory reaction. This might be a reaction to vessel wall injury that accompanies infections, immune disease, and perhaps diabetes and renal failure. In this chapter, we will focus on the relationship between de novo synthesis of sphingolipids and lipid metabolism, atherosclerosis, and cardiomyopathy.

Topics: Animals; Apoptosis; Atherosclerosis; Cardiomyopathies; Cardiovascular Diseases; Cholesterol; Coronary Disease; Endothelium, Vascular; Fatty Acids; Fatty Acids, Monounsaturated; Humans; Inflammation; Lipoproteins; MAP Kinase Signaling System; Models, Cardiovascular; Serine C-Palmitoyltransferase; Sphingolipids; Transferases (Other Substituted Phosphate Groups)